Prototype CT tools for minimally invasive intracerebral hemorrhage evacuation
Feasibility of the Utilization of Siemens Prototypes in Minimally Invasive ICH Evacuation Treatment
This project will test two Siemens prototype CT tools—a perfusion feature and an automatic hemorrhage detector—to see if they help doctors planning and performing minimally invasive brain-bleed (intracerebral hemorrhage) evacuation in adults.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT07455201 on ClinicalTrials.gov |
What this trial studies
The project prospectively collects pre-procedural CT scans, intra-procedural DynaCT Sine Spin and DynaCT Multiphase scans taken immediately after evacuation, and immediate post-procedural CT scans to test two Siemens prototypes (a perfusion prototype and an automatic hemorrhage detection prototype). In addition, five retrospectively collected pre- and post-procedural datasets acquired during routine care will be included. Treating clinicians will provide structured feedback on feasibility, usefulness, and potential clinical value during minimally invasive ICH procedures at Mount Sinai West. The aim is to characterize operational performance and identify potential workflow and outcome benefits of these imaging features.
Who should consider this trial
Good fit: Adults (age ≥18) who are scheduled to undergo minimally invasive hemorrhage evacuation at Mount Sinai West are eligible.
Not a fit: Patients under 18, or those not undergoing minimally invasive hemorrhage evacuation at Mount Sinai West, are not eligible and unlikely to benefit from these specific prototypes.
Why it matters
Potential benefit: If successful, these CT prototypes could help surgeons locate and confirm clot removal more quickly and accurately, potentially improving recovery and reducing complications.
How similar studies have performed: Imaging-guided approaches for ICH have shown promise, but the specific Siemens perfusion and automatic-bleed-detection prototypes tested here are relatively new and have limited published clinical data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ≥ 18 years old * Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital Exclusion Criteria: * Patient is \< 18 years old * Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Where this trial is running
New York, New York
- Mount Sinai West — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Christopher Kellner — Icahn School of Medicine at Mount Sinai
- Study coordinator: Emily Svendsen
- Email: Emily.Svendsen@mountsinai.org
- Phone: 212-241-3238
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.